Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century
Lazzarini PA, Cramb SM, Golledge J, et al.
Diabetologia. Pub. online 13 Dec 2022.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Retinopathy during the first 5 years of type 1 diabetes and subsequent risk of advanced retinopathy
Malone JI, Gao X, Lorenzi GM, et al.
Diabetes Care. dc221711.
Leggi
Improved glycemia with Hybrid Closed-Loop (HCL) versus Continuous Subcutaneous Insulin Infusion (CSII) therapy: results from a randomized controlled trial
Garg SK, Grunberger G, Weinstock RS, et al.
Diabetes Technol Ther. Pub. online 6 Dec 2022.
Leggi
A Comparison of CGM estimated hemoglobin A1c in adults with type 1 or type 2 diabetes
Salam M, Bailey R, Calhoun P, et al.
Diabetes Technol Ther. Pub. online 6 Dec 2022.
Leggi
Impact of expanding access to continuous glucose monitoring systems among insulin users with type 1 or type 2 diabetes
Pathak S, Kearin K, Kahkoska A et al.
Diabetes Technol Ther. Pub. online 8 Dec 2022.
Leggi
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy
Maalmi H, Strom A, Petrera A, et al.
Diabetologia. Pub. online 6 Dec 2022.
Leggi
Associations between diabetic retinopathy, mortality, disease, and mental health: an umbrella review of observational meta-analyses
Trott M, Driscoll R, Pardhan S
BMC Endocr Disord. 2022;22(1):311.
Leggi
Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort study
Cheung JTK, Yang A, Wu H, et al.
Diabetes Res Clin Pract. Pub. online 6 Dec 2022.
Leggi
Comparison of sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist prescribing in patients with diabetes mellitus with and without cardiovascular disease
Gay HC, Yu J, Persell SD, et al.
Am J Cardiol. 2022;S0002-9149(22)01131-6.
Leggi
Two decades of diabetes prevention efforts: a call to innovate and revitalize our approach to lifestyle change
Golovaty I, Ritchie ND, Tuomilehto J, et al.
Diabetes Res Clin Pract. 2022;110195.
Leggi